Exploring New and Growth Fields and Early Commercialization of New Businesses
First written in FY2016. 15 of 21 entries say "Restated". Latest entry: 2026-05-11.
47 other companies' latest entry also says "Restated".
- 2026-05-11RestatedEarnings
「We expect firm demand over the medium term for inspection equipment for the semiconductor manufacturing industry in the inspection and measurement equipment and industrial equipment fields, as well as for the medical field, and will promote business-structure reforms to address this demand.」
Inspection equipment for the semiconductor manufacturing industry and the medical field were identified as areas of medium-term demand, and business-structure reforms continued. - FY2026-H1RestatedAnnual report
「Over the medium to long term, we worked to strengthen sales and product development to win orders for semiconductor-related products, where growth is expected, while continuing to focus on developing product areas addressing new ways of working and office design in the office furniture business, one of the Group's core businesses.」
We continued to target winning orders for semiconductor-related products and developing product areas addressing new ways of working and office design. - FY2025-H1RestatedAnnual report
「Over the medium to long term, we worked to develop and strengthen sales of products for the semiconductor industry, where growth is expected, while in the office furniture business, one of the Group's core businesses, we focused on developing products for new ways of working and office design.」
We continued to strengthen the development and sales of semiconductor-related products and expand product areas addressing new ways of working and office design. - FY2024AdvancedAnnual report
「We also commercialize new products and businesses in new fields where we can apply the expertise of our existing businesses by using sales information across the Group, while working to improve speed, establish new businesses as a foundation at an early stage and secure future growth, which we recognize as important priorities.」
We reaffirmed the policy of establishing new businesses as an operating foundation at an early stage and also reported the concrete commercialization milestone of launching sales of clinical laboratory testing products. - FY2024-Q1AdvancedAnnual report
「Against this backdrop, we worked to establish a production structure and shift our business portfolio mainly to meet increased semiconductor-related demand, while focusing on preparations to enter the in-vitro diagnostic products market, which we had been developing as a new business.」
In developing new and growth areas, we showed concrete progress in the new business of preparing to enter the in-vitro diagnostic products market, in addition to responding to semiconductor-related demand. - FY2023AdvancedAnnual report
「The objective is to expand the welfare and healthcare business within the Group's residential lifestyle equipment segment.」
As part of efforts to develop new and growth areas, we completed the acquisition of a subsidiary to expand the welfare and healthcare business and moved toward expanding the sales structure. - FY2023-Q3AdvancedAnnual report
「In the Group's residential lifestyle equipment segment, we are working to expand the business by strengthening our core office products and identifying the welfare and healthcare products market as an area requiring greater focus.」
Welfare and healthcare were clearly positioned as new and growth areas, leading to an acquisition aimed at expanding the sales structure. - FY2020RestatedAnnual report
「The company recognizes that accelerating the commercialization of new businesses, launching them at an early stage, and securing future growth are important challenges.」
The early launch of new businesses and faster commercialization continued to be key priorities. - FY2020-Q3RestatedAnnual report
「・Accelerate active investment and commercialization in the medical equipment-related business field」
The company continued to prioritize active investment in the medical equipment-related field and accelerated commercialization. - FY2020-Q2RaisedAnnual report
「・Accelerate active investment and commercialization in the medical equipment-related business field」
For the medical equipment-related field among its new businesses and growth fields, the company strengthened its policy from conventional product development and market introduction to explicitly emphasizing active investment and accelerated commercialization. - FY2020-Q1RestatedAnnual report
「While focusing on expanding the global sales and procurement structures and various business alliance and new business development activities」
The company continued business alliance and new business development activities as means of developing new growth fields. - FY2019-Q3RestatedAnnual report
「In addition, while focusing on product development and sales activities, various business alliance activities, and expanding the global sales and procurement structures」
The company continued product development and sales activities and business alliance activities as means of developing new and growth fields. - FY2019-Q2RestatedAnnual report
「In addition, while focusing on product development and sales activities, various business alliance activities, and expanding the global sales and procurement structures」
The company continued product development and sales activities and business alliance activities as means of developing new and growth fields. - FY2019-Q1RestatedAnnual report
「Specifically, while focusing on product development and sales activities, various business alliance activities, and expanding the global sales and procurement structures」
The company continued product development and sales activities and business alliance activities as means of developing new and growth fields. - FY2018-Q3RestatedAnnual report
「The company focuses on product development and sales activities related to new sales fields, various business alliance activities, and expanding the global sales structure」
The company continued product development and sales activities in new sales fields and business alliances as means of developing new and growth fields. - FY2018-Q2RestatedAnnual report
「Specifically, while focusing on product development and sales activities related to new sales fields, various business alliance activities, and expanding the global sales structure」
The company continued product development and sales activities related to new sales fields as measures to develop growth fields. - FY2018-Q1RestatedAnnual report
「Specifically, while focusing on product development and sales activities related to new sales fields and expanding the global sales structure」
The company continued product development and sales activities for new sales fields as measures to develop growth fields. - FY2017-Q3RestatedAnnual report
「Specifically, while focusing on developing new core technologies, developing products for new sales fields, and expanding the global sales structure」
The company continued developing new core technologies and products for new sales fields as measures to develop growth fields. - FY2017-Q2RestatedAnnual report
「Specifically, while focusing on developing new core technologies, developing products for new sales fields, and expanding the global sales structure」
The company continued developing new core technologies and products for new sales fields as measures to develop growth fields. - FY2017-Q1RestatedAnnual report
「Specifically, while focusing on developing new core technologies, developing products for new sales fields, and expanding the global sales structure」
The company continued developing new core technologies and products for new sales fields as measures targeting new growth fields. - FY2016First statedAnnual report
「The company recognizes that accelerating the commercialization of new businesses, launching them at an early stage, and securing future growth are important challenges.」
The company identified bringing forward the launch of new businesses as a challenge in securing growth.